Cyclothiazide, AMPA receptor desensitisation inhibitor
Cyclothiazide, AMPA receptor desensitisation inhibitor
Be the first to review this product! Submit a review
|
(18 Publications)
MW 389.9 Da, Purity >98%. Positive allosteric modulator of AMPA receptors. Produces a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current. Also available in Kit: Ionotropic agonists (ab120323).
查看别名
AMPA 1, AMPA 2, AMPA 3, AMPA 4, AMPA-selective glutamate receptor 1, AMPA-selective glutamate receptor 2, AMPA-selective glutamate receptor 3, AMPA-selective glutamate receptor 4, GLUH1, GLUK3, GLUR4C, GRIA1_HUMAN, GRIA2_HUMAN, GRIA3_HUMAN, GRIA4_HUMAN, GluA 4, GluA1, GluA2, GluA3, GluR-1, GluR-2, GluR-3, GluR-4, GluR-A, GluR-B, GluR-C, GluR-D, GluR-K1, GluR-K2, GluR-K3, Glutamate ionotropic receptor AMPA type subunit 3, Glutamate receptor 1, Glutamate receptor 2, Glutamate receptor 3, Glutamate receptor 4, Glutamate receptor C, Glutamate receptor ionotrophic AMPA 3, Glutamate receptor ionotrophic AMPA 4, Glutamate receptor ionotropic, Glutamate receptor ionotropic AMPA 1, Glutamate receptor ionotropic AMPA 2, Glutamate receptor subunit 3, Glutamate receptor, ionotropic, AMPA 3, HBGR1, HBGR2, Ionotrophic Glutamate Receptor, Ionotropic Glutamate receptor 4, MGC133252, MRX94, OTTHUMP00000160643, OTTHUMP00000165781, OTTHUMP00000224241, OTTHUMP00000224242, OTTHUMP00000224243, dJ1171F9.1
- CellAct
Unknown
Cellular Activation - Cyclothiazide, AMPA receptor desensitisation inhibitor (AB120061)
To determine the capability of VCN-LSO synapses to support repetitive activity in the developing circuit, we added cyclothiazide to the perfusate to prevent AMPAR desensitization and measured responses to 50 Hz pulse-train stimuli delivered to the ventral acoustic stria. A. Representative responses to 50 Hz pulse-trains in P2, P5, and P9 cells; responses to the first five pulses only are shown. Greater paired-pulse depression between pulse 1 and 2 is evident in the youngest cell than in the older cells.
Image from Case DT, et al. Plos One, 6(6), e20756. Fig S4,; doi: 10.1371/journal.pone.0020756
- Chemical Structure
Lab
Chemical Structure - Cyclothiazide, AMPA receptor desensitisation inhibitor (AB120061)
2D chemical structure image of ab120061, Cyclothiazide, AMPA receptor desensitisation inhibitor
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The AMPA receptors facilitate neuronal communication and plasticity by modulating synaptic strength. This modulation occurs through processes such as potentiation and desensitisation where the receptor's response to glutamate changes. Potentiated sulfonamides like cyclothiazide can influence AMPA receptor activity by preventing desensitization maintaining prolonged neurotransmission. Cyclothiazide itself binds within the AMPA structure altering the conformation to prevent the desensitised state which is key in sustaining synaptic efficacy. AMPA receptors also interact with auxiliary proteins like TARPs (Transmembrane AMPA Receptor Regulatory Proteins) that assist in their trafficking and channel properties.
Pathways
AMPA receptors play a significant role in the glutamatergic pathway integral for synaptic transmission and neuroplasticity. This pathway influences learning and memory processes. AMPA receptors also interact with the NMDA receptors in long-term potentiation (LTP) a process critical for memory formation and synaptic strength. Additionally they connect with proteins like CaMKII (Calcium/Calmodulin-dependent protein kinase II) during signal transduction processes inside neurons important for cellular responses following synaptic activation.
文献 (18)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in cellular neuroscience 12:513 PubMed30670950
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & phar 101:362-370 PubMed29499411
2018
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 10:402 PubMed29276473
2017
Applications
Unspecified application
Species
Unspecified reactive species
The European journal of neuroscience 46:2519-2533 PubMed28921719
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:44817 PubMed28322255
2017
Applications
Unspecified application
Species
Unspecified reactive species
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 369:20130602 PubMed25225096
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 34:11673-83 PubMed25164663
2014
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 34:980-91 PubMed24431456
2014
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta 1833:1820-31 PubMed23545413
2013
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 14:1430-8 PubMed21983683
2011
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com